FARXIGA: payments to doctors
Payments that named FARXIGA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $58.1M
- Providers
- 143,382
- Transactions
- 1,108,823
- Average per transaction
- $52
The per-transaction average — $52 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 143,382 providers the average total is $405, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| AstraZeneca | $57,497,784 | 99.0% |
| Astrazeneca UK Limited | $330,602 | 0.6% |
| Astrazeneca AB | $261,999 | 0.5% |
| Acerta Pharma LLC | $4,749 | 0.0% |